OSIRIS: A diffraction limited integral field spectrograph for Keck
James Larkin(Trinity College Dublin), S. Wright(University of California San Diego), John Canfield(University of California, Los Angeles), Jason Weiss(University of California, Los Angeles), Nick Magnone(University of California, Los Angeles), Sean M. Adkins(W.M. Keck Observatory), C. Iserlohe(TH Köln - University of Applied Sciences), Juleen Moon(University of California, Los Angeles), Michael Spencer(University of California, Los Angeles), David Lafreniére(Université de Montréal), Evan Kress(University of California, Los Angeles), Michael W. McElwain(Goddard Space Flight Center), Chris A. Johnson(Oklahoma State University), M. Barczys(University of California, Los Angeles), Paola Amico(Nia Association), Inseok Song(University of Georgia), Allan Honey(Nia Association), George Brims(University of California, Los Angeles), A. Quirrenbach(Heidelberg University), Randy Campbell(Nia Association), Ken Magnone(University of California, Los Angeles), Ted Aliado(University of California, Los Angeles), A. Krabbe(University of California, Berkeley), Thomas M. Gasaway(University of California San Diego), Gunnar E. Skulason(University of California, Los Angeles)
Cited by 140
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Pembrolizumab versus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2015|5.9k
Transiting Exoplanet Survey Satellite
|Journal of Astronomical Telescopes Instruments and Systems|2014|4.1k
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2019|3.7k
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
|New England Journal of Medicine|2017|2.2k